Developer docs
API playgroundTry for free, no card

Search company profiles

JC Biotech

Full company profile

uuid0031wx9

Namestring
JC Biotech
Legal namestring
JC Biotech Private Limited
Websiteurl
jcbiotech.com
Company typeenum
Private
Founded yearint
2004
Descriptiontext

JC Biotech Private Limited is an Indian specialty fermentation manufacturer founded in 2004 that produces nutraceuticals, bio-pharmaceuticals, and biochemicals used in the synthesis of active pharmaceutical ingredients (APIs). The company operates a 30-acre GMP-compliant manufacturing site at the APIIC Growth Centre in Prakasam District, Andhra Pradesh, supported by a corporate office in Hyderabad, Telangana. It was established under the guidance of Late Sri. S. Koteswara Rao, founder of Bhagiradha Chemicals & Industries, with S. Chandra Sekhar serving as Promoter and Managing Director.

The company's core technology is a semi-automated aerobic fermentation platform with fermenter capacities ranging from 50 L to 33,000 L, monitored via a Distributed Control System (DCS) for temperature, pH, and dissolved oxygen, and complemented by a versatile downstream processing train (membrane filtration, extraction, centrifugation, Nutsche/Sparkler filtration, tray drying and lyophilization) that can simultaneously process two products. In-house synthetic chemistry capability covers esterification, trans-esterification, hydrogenation, chlorination, and halex reactions, with fermenters and vessels fabricated to ASME Sec VIII Div 1 2001 and ASME BPE 2005 codes. Marketed products are Serratiopeptidase (a Serratia marcescens-derived protease API compliant with Indian Pharmacopoeia 2010, with activity up to 2600 u/mg) and DHA 35% oil (an omega-3 ingredient from Schizochytrium microalgae fermentation); a four-product pipeline (Sirolimus, Pneumocandin B0, Thymine, Beta-Thymidine) was disclosed for March 2012 commercialization. JC Biotech became the first company to obtain Indian Pharmacopoeia drug licences for Serratiopeptidase in June 2011, providing an early regulatory foothold.

Revenue is generated through a quote-based B2B ingredient sales model, with Serratiopeptidase priced per u/mg activity and DHA oil priced per kg, sold directly to pharmaceutical and nutraceutical manufacturers primarily in India. The go-to-market motion is relationship-driven enterprise field sales (phone, fax, email, contact form) with no self-serve, marketplace, or digital channels. The company employs 11-50 people, has not disclosed external investors, and has not reported revenue; cumulative disclosed plant investment stands at Rs. 42.0 crores, with operations confirmed through the FY 2021-2022 CSR Annexure.

Short descriptiontext

JC Biotech Private Limited is an Indian specialty fermentation manufacturer founded in 2004 that produces the bio-pharmaceutical API Serratiopeptidase and DHA omega-3 oil from a GMP-compliant plant in Andhra Pradesh, selling B2B to pharmaceutical and nutraceutical manufacturers in India.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersHyderabad, India
HQ citystring
Hyderabad
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Keyword5 values
active pharmaceutical ingredients, nutraceutical manufacturing, fermentation technology, bio-pharmaceutical APIs, omega-3 fatty acid production
Industry3 codes
PRIMARYHLAIAJAO
Compounding Ingredient & API Distributors (Pharma Supply)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYHLAGAHAB
Small-Molecule API Commercial Manufacturing
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAAAKAA
Biologic API/Drug Substance Manufacturing Services
NAICS code3 codes
  • Biological Product (except Diagnostic) Manufacturing325414
  • Dairy Product Manufacturing3115
  • Food Manufacturing311
SIC code5 codes
  • Dairy Products2020
  • Medicinal Chemicals & Botanical Products2833
  • Biological Products, (No Disgnostic Substances)2836
  • Food And Kindred Products2000
  • Industrial Organic Chemicals2860
Product category
Bio-pharmaceutical API Manufacturing
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Serratiopeptidase API sales
TypeOne Time License
Description

B2B sale of Serratiopeptidase as an active pharmaceutical ingredient (API) manufactured through aerobic fermentation of Serratia marcescens, supplied as off-white to cream-coloured powder with activity up to 2600 u/mg, compliant with Indian Pharmacopeia 2010 specifications.

jcbiotech.com
2DHA (Docosahexaenoic Acid) oil sales
TypeOne Time License
Description

B2B sale of DHA 35% oil produced by fermentation from marine microalgae Schizochytrium sp., supplied as fluid to waxy pale yellow to orange oil, marketed to nutraceutical manufacturers (min. 32% DHA content).

jcbiotech.com
3Pipeline / R&D product commercialization
TypeOne Time License
Description

Future revenue from commercialization of R&D pipeline products (Sirolimus CAS 53123-88-9; Pneumocandin B0 CAS 135575-42-7; Thymine CAS 65-71-4; Beta-Thymidine CAS 50-89-5) targeted for launch by March 2012.

jcbiotech.com
Cost components6 values
Operations, Personnel, Technology or R&D, Supply Chain, Infrastructure, Marketing or Sales
Pricing details1 tier
1Quote-based B2B ingredient pricing
ModelUnit PricingBilling cadenceMulti-year contract
Notes

Pricing per u/mg activity for Serratiopeptidase (NLT 2000 u/mg standard, up to 2600 u/mg offered) and per kg for DHA 35% oil; quote-based, not publicly disclosed; available via contact form, phone, or email.

jcbiotech.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

JC Biotech manufactures nutraceutical, bio-pharmaceutical, and biochemical active pharmaceutical ingredients (APIs) using aerobic fermentation. Its commercial products include Serratiopeptidase (a proteolytic enzyme API) and DHA 35% oil (an omega-3 fatty acid), sold B2B to pharmaceutical and nutraceutical manufacturers. The company also has an R&D pipeline of fermentation/synthetic products targeted for future commercialization.

Differentiator
Functional benefit
Problem solved
Product and service2 records
1Serratiopeptidase
CategoryBio-pharmaceutical API (Proteolytic Enzyme)
Description

Serratiopeptidase is a proteolytic enzyme (protease, 52 KD molecular weight) produced by Serratia marcescens through aerobic fermentation. It is identified and analyzed per Indian Pharmacopeia 2010, supplied as an off-white to cream coloured powder with typical activity of 2120 u/mg, customizable up to 2600 u/mg. Sold as an API to pharmaceutical manufacturers.

2DHA (Docosahexaenoic Acid) Oil
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Indian biopharmaceutical company with substantial fermentation-based biologics and API manufacturing; while much larger and biologics-focused, it is a relevant comparable for Indian fermentation API infrastructure and a potential strategic acquirer.

TypeDirect peer
Description

Indian fermentation company producing vitamin D3, penicillin derivatives and other fermentation APIs/enzymes; comparable fermentation-driven API business model and Indian mid-cap scale relevant to JC Biotech's Serratiopeptidase and DHA franchise.

TypeBroad incumbent
Description

Larger Indian API and CDMO platform with fermentation, synthetic chemistry and finished dosage capabilities; competes with JC Biotech in the broader Indian API market and could be a strategic acquirer of a niche fermentation asset like JC Biotech.

TypeBroad incumbent
Description

One of India's largest API manufacturers with strong fermentation and synthetic-chemistry capabilities supplying global generics; relevant comparable for JC Biotech's scale-up trajectory and as a potential strategic partner for international expansion.

TypeDirect peer
Description

Indian fermentation-based API manufacturer specializing in immunosuppressants and other high-value fermentation APIs; directly comparable technology stack (microbial fermentation, downstream purification) and product overlap with JC Biotech's Sirolimus pipeline ambitions.

TypeDirect peer
Description

Bengaluru-based fermentation-driven contract development and manufacturing organization focused on APIs and intermediates; comparable in scale and fermentation platform to JC Biotech and competes for similar Indian and global API customers.

TypeBroad incumbent
Description

Global CDMO/API services platform with significant fermentation capacity; comparable technology base and could be a strategic partner or acquirer interested in JC Biotech's fermentation platform and Indian manufacturing footprint.

TypeBroad incumbent
Description

Large Indian vertically-integrated pharma with significant fermentation-based API manufacturing; while much bigger, it operates in the same Indian API supply ecosystem and is a potential bulk buyer or competitor for JC Biotech's Serratiopeptidase output.

TypeDirect peer
Description

Founded by S. Koteswara Rao (the mentor under whom JC Biotech was incubated), Bhagiradha is an Indian specialty chemicals and crop-science/API manufacturer with overlapping fermentation/synthetic chemistry capability and a similar Hyderabad footprint, making it the closest lineage and capability peer.

10Pharmanza Herbal
TypeEmerging player
Description

Smaller Indian API and nutraceutical ingredient manufacturer; comparable in scale and product mix (APIs plus nutraceutical ingredients) to JC Biotech and a useful peer for small-cap Indian specialty ingredient valuation reference.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

JC Biotech

Bio-pharmaceutical API Manufacturingjcbiotech.com

JC Biotech Private Limited is an Indian specialty fermentation manufacturer founded in 2004 that produces the bio-pharmaceutical API Serratiopeptidase and DHA omega-3 oil from a GMP-compliant plant in Andhra Pradesh, selling B2B to pharmaceutical and nutraceutical manufacturers in India.

What JC Biotech does

JC Biotech Private Limited is an Indian specialty fermentation manufacturer founded in 2004 that produces nutraceuticals, bio-pharmaceuticals, and biochemicals used in the synthesis of active pharmaceutical ingredients (APIs). The company operates a 30-acre GMP-compliant manufacturing site at the APIIC Growth Centre in Prakasam District, Andhra Pradesh, supported by a corporate office in Hyderabad, Telangana. It was established under the guidance of Late Sri. S. Koteswara Rao, founder of Bhagiradha Chemicals & Industries, with S. Chandra Sekhar serving as Promoter and Managing Director.

The company's core technology is a semi-automated aerobic fermentation platform with fermenter capacities ranging from 50 L to 33,000 L, monitored via a Distributed Control System (DCS) for temperature, pH, and dissolved oxygen, and complemented by a versatile downstream processing train (membrane filtration, extraction, centrifugation, Nutsche/Sparkler filtration, tray drying and lyophilization) that can simultaneously process two products. In-house synthetic chemistry capability covers esterification, trans-esterification, hydrogenation, chlorination, and halex reactions, with fermenters and vessels fabricated to ASME Sec VIII Div 1 2001 and ASME BPE 2005 codes. Marketed products are Serratiopeptidase (a Serratia marcescens-derived protease API compliant with Indian Pharmacopoeia 2010, with activity up to 2600 u/mg) and DHA 35% oil (an omega-3 ingredient from Schizochytrium microalgae fermentation); a four-product pipeline (Sirolimus, Pneumocandin B0, Thymine, Beta-Thymidine) was disclosed for March 2012 commercialization. JC Biotech became the first company to obtain Indian Pharmacopoeia drug licences for Serratiopeptidase in June 2011, providing an early regulatory foothold.

Revenue is generated through a quote-based B2B ingredient sales model, with Serratiopeptidase priced per u/mg activity and DHA oil priced per kg, sold directly to pharmaceutical and nutraceutical manufacturers primarily in India. The go-to-market motion is relationship-driven enterprise field sales (phone, fax, email, contact form) with no self-serve, marketplace, or digital channels. The company employs 11-50 people, has not disclosed external investors, and has not reported revenue; cumulative disclosed plant investment stands at Rs. 42.0 crores, with operations confirmed through the FY 2021-2022 CSR Annexure.

JC Biotech firmographics

Firmographics
Name
JC Biotech
Legal name
JC Biotech Private Limited
Website
https://jcbiotech.com
Company type
Private
Founded year
2004
Operating status
Operating
Headcount range
51–100 employees
Short description
JC Biotech Private Limited is an Indian specialty fermentation manufacturer founded in 2004 that produces the bio-pharmaceutical API Serratiopeptidase and DHA omega-3 oil from a GMP-compliant plant in Andhra Pradesh, selling B2B to pharmaceutical and nutraceutical manufacturers in India.
Ownership category
akta.pro rank

JC Biotech industry classification

Industry
Product category
Bio-pharmaceutical API Manufacturing
NAICS
Biological Product (except Diagnostic) Manufacturing (325414), Dairy Product Manufacturing (3115), Food Manufacturing (311)
SIC
Dairy Products (2020), Medicinal Chemicals & Botanical Products (2833), Biological Products, (No Disgnostic Substances) (2836), Food And Kindred Products (2000), Industrial Organic Chemicals (2860)
akta.pro industry
PRIMARYHLAIAJAO
Compounding Ingredient & API Distributors (Pharma Supply)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYHLAGAHAB
Small-Molecule API Commercial Manufacturing
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAAAKAA
Biologic API/Drug Substance Manufacturing Services

Keywords

  • Active pharmaceutical ingredients
  • Nutraceutical manufacturing
  • Fermentation technology
  • Bio-pharmaceutical APIs
  • Omega-3 fatty acid production

Where JC Biotech is headquartered

Location

Headquarters

HQ city
Hyderabad
HQ country
India
HQ region
Asia

Markets served

JC Biotech business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Personnel, Technology or R&D, Supply Chain, Infrastructure, Marketing or Sales

Revenue model

  1. Serratiopeptidase API sales: B2B sale of Serratiopeptidase as an active pharmaceutical ingredient (API) manufactured through aerobic fermentation of Serratia marcescens, supplied as off-white to cream-coloured powder with activity up to 2600 u/mg, compliant with Indian Pharmacopeia 2010 specifications.
  2. DHA (Docosahexaenoic Acid) oil sales: B2B sale of DHA 35% oil produced by fermentation from marine microalgae Schizochytrium sp., supplied as fluid to waxy pale yellow to orange oil, marketed to nutraceutical manufacturers (min. 32% DHA content).
  3. Pipeline / R&D product commercialization: Future revenue from commercialization of R&D pipeline products (Sirolimus CAS 53123-88-9; Pneumocandin B0 CAS 135575-42-7; Thymine CAS 65-71-4; Beta-Thymidine CAS 50-89-5) targeted for launch by March 2012.

Pricing tiers

ModelBillingPrice
Unit PricingMulti-year contractQuote-based B2B ingredient pricing

Go-to-market motion1 record

JC Biotech product offering

Product offering

Core offering

JC Biotech manufactures nutraceutical, bio-pharmaceutical, and biochemical active pharmaceutical ingredients (APIs) using aerobic fermentation. Its commercial products include Serratiopeptidase (a proteolytic enzyme API) and DHA 35% oil (an omega-3 fatty acid), sold B2B to pharmaceutical and nutraceutical manufacturers. The company also has an R&D pipeline of fermentation/synthetic products targeted for future commercialization.

Differentiator

Problem solved

Functional benefit

Products and services

  • Serratiopeptidase Serratiopeptidase is a proteolytic enzyme (protease, 52 KD molecular weight) produced by Serratia marcescens through aerobic fermentation. It is identified and analyzed per Indian Pharmacopeia 2010, supplied as an off-white to cream coloured powder with typical activity of 2120 u/mg, customizable up to 2600 u/mg. Sold as an API to pharmaceutical manufacturers.
  • DHA (Docosahexaenoic Acid) Oil

Companies that use JC Biotech

Customer profile

Ideal customer profiles1 record

JC Biotech technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

JC Biotech partnerships and signals

Strategic signal

Recent moves6 records

Expansion highlights4 records

JC Biotech competitors and assessment

Company assessment

Broad incumbents

  • Biocon Limited: Indian biopharmaceutical company with substantial fermentation-based biologics and API manufacturing; while much larger and biologics-focused, it is a relevant comparable for Indian fermentation API infrastructure and a potential strategic acquirer.
  • Laurus Labs: Larger Indian API and CDMO platform with fermentation, synthetic chemistry and finished dosage capabilities; competes with JC Biotech in the broader Indian API market and could be a strategic acquirer of a niche fermentation asset like JC Biotech.
  • Divis Laboratories: One of India's largest API manufacturers with strong fermentation and synthetic-chemistry capabilities supplying global generics; relevant comparable for JC Biotech's scale-up trajectory and as a potential strategic partner for international expansion.
  • Piramal Pharma Solutions: Global CDMO/API services platform with significant fermentation capacity; comparable technology base and could be a strategic partner or acquirer interested in JC Biotech's fermentation platform and Indian manufacturing footprint.
  • Aurobindo Pharma: Large Indian vertically-integrated pharma with significant fermentation-based API manufacturing; while much bigger, it operates in the same Indian API supply ecosystem and is a potential bulk buyer or competitor for JC Biotech's Serratiopeptidase output.

Direct peers

  • Fermenta Biotech Limited: Indian fermentation company producing vitamin D3, penicillin derivatives and other fermentation APIs/enzymes; comparable fermentation-driven API business model and Indian mid-cap scale relevant to JC Biotech's Serratiopeptidase and DHA franchise.
  • Concord Biotech: Indian fermentation-based API manufacturer specializing in immunosuppressants and other high-value fermentation APIs; directly comparable technology stack (microbial fermentation, downstream purification) and product overlap with JC Biotech's Sirolimus pipeline ambitions.
  • Anthem Biosciences: Bengaluru-based fermentation-driven contract development and manufacturing organization focused on APIs and intermediates; comparable in scale and fermentation platform to JC Biotech and competes for similar Indian and global API customers.
  • Bhagiradha Chemicals & Industries Limited: Founded by S. Koteswara Rao (the mentor under whom JC Biotech was incubated), Bhagiradha is an Indian specialty chemicals and crop-science/API manufacturer with overlapping fermentation/synthetic chemistry capability and a similar Hyderabad footprint, making it the closest lineage and capability peer.

Emerging players

  • Pharmanza Herbal: Smaller Indian API and nutraceutical ingredient manufacturer; comparable in scale and product mix (APIs plus nutraceutical ingredients) to JC Biotech and a useful peer for small-cap Indian specialty ingredient valuation reference.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

JC Biotech social profiles

Digital presence

JC Biotech compliance and trust

Trust signal

Compliance3 records

JC Biotech financial estimates

Financial estimate

Revenue estimate

Valuation estimate

JC Biotech leadership team

Management profile

Number of profiles

Profiles1 record

JC Biotech funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

JC Biotech M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about JC Biotech

What does JC Biotech do?

JC Biotech manufactures nutraceutical, bio-pharmaceutical, and biochemical active pharmaceutical ingredients (APIs) using aerobic fermentation. Its commercial products include Serratiopeptidase (a proteolytic enzyme API) and DHA 35% oil (an omega-3 fatty acid), sold B2B to pharmaceutical and nutraceutical manufacturers. The company also has an R&D pipeline of fermentation/synthetic products targeted for future commercialization.

Is JC Biotech a public or private company?

JC Biotech is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was JC Biotech founded?

JC Biotech was founded in 2004. It employs 51 to 100 people.

Where is JC Biotech based?

JC Biotech is headquartered in Hyderabad, India, in the Asia region.

How does JC Biotech make money?

Three revenue lines are on record. Serratiopeptidase API sales are the primary driver. The others are DHA (Docosahexaenoic Acid) oil sales and pipeline / R&D product commercialization.

Who are JC Biotech's main competitors?

Broad incumbents on record are Biocon Limited, Laurus Labs, Divis Laboratories, Piramal Pharma Solutions and Aurobindo Pharma. Direct peers are Fermenta Biotech Limited, Concord Biotech, Anthem Biosciences and Bhagiradha Chemicals & Industries Limited. Pharmanza Herbal is listed as an emerging player.

Does JC Biotech have an API?

No public API is recorded for JC Biotech.

What industry is JC Biotech in?

JC Biotech's product category is Bio-pharmaceutical API Manufacturing. Its primary akta.pro industry code is HLAIAJAO, Compounding Ingredient & API Distributors (Pharma Supply), with a secondary code of HLAGAHAB, Small-Molecule API Commercial Manufacturing. Its NAICS code is 325414 and its SIC code is 2020.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals